新光药业
(300519)
| 流通市值：19.39亿 | | | 总市值：27.18亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 205,618,567.89 | 140,942,929.2 | 93,250,095.71 | 267,659,927.41 |
| 营业收入 | 205,618,567.89 | 140,942,929.2 | 93,250,095.71 | 267,659,927.41 |
| 二、营业总成本 | 155,285,531.11 | 108,227,514.07 | 66,920,864.51 | 217,460,556.34 |
| 营业成本 | 125,173,396.18 | 89,363,811.65 | 58,941,107.85 | 177,116,596.25 |
| 税金及附加 | 3,605,166.86 | 2,413,791.93 | 1,654,805.85 | 4,503,032.44 |
| 销售费用 | 14,179,746.86 | 10,766,493.8 | 5,695,841.03 | 24,371,913.87 |
| 管理费用 | 13,316,157.76 | 9,356,667.78 | 4,619,139.89 | 17,512,159.92 |
| 研发费用 | 10,041,721.84 | 6,985,742.65 | 4,277,457.45 | 12,624,156.44 |
| 财务费用 | -11,030,658.39 | -10,658,993.74 | -8,267,487.56 | -18,667,302.58 |
| 其中:利息收入 | 11,040,362.05 | 10,666,340.74 | 8,271,108.09 | 18,680,938.96 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 2,927,590.47 | 2,185,287.2 | 815,308 | 4,869,269.7 |
| 资产处置收益 | -3,722.27 | -3,722.27 | -3,722.27 | -67,847.01 |
| 资产减值损失(新) | -62,904.72 | -177,676.58 | -96,677.41 | -390,462.36 |
| 信用减值损失(新) | -34,170.9 | 47,189.54 | 216,044.91 | -109,696.09 |
| 其他收益 | 1,862,616.76 | 1,305,497.17 | 667,271.64 | 2,844,958.6 |
| 四、营业利润 | 55,022,446.12 | 36,071,990.19 | 27,927,456.07 | 57,345,593.91 |
| 加:营业外收入 | 295,080.08 | 229,943.2 | 226,249.4 | 675,188 |
| 减:营业外支出 | 1,745,786.82 | 16,449.8 | 43.5 | 1,014,700 |
| 五、利润总额 | 53,571,739.38 | 36,285,483.59 | 28,153,661.97 | 57,006,081.91 |
| 减:所得税费用 | 8,235,561.04 | 4,377,787.18 | 3,611,880.86 | 6,616,088.92 |
| 六、净利润 | 45,336,178.34 | 31,907,696.41 | 24,541,781.11 | 50,389,992.99 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 45,336,178.34 | 31,907,696.41 | 24,541,781.11 | 50,389,992.99 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 45,336,178.34 | 31,907,696.41 | 24,541,781.11 | 50,389,992.99 |
| 扣除非经常损益后的净利润 | 43,488,621.89 | 29,439,271.34 | 23,366,499.56 | 45,393,968.53 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.28 | 0.2 | 0.15 | 0.31 |
| (二)稀释每股收益 | 0.28 | 0.2 | 0.15 | 0.31 |
| 八、其他综合收益 | 80,363.36 | 218,506.15 | -66,771.95 | 21,068.42 |
| 归属于母公司股东的其他综合收益 | 80,363.36 | 218,506.15 | -66,771.95 | 21,068.42 |
| 九、综合收益总额 | 45,416,541.7 | 32,126,202.56 | 24,475,009.16 | 50,411,061.41 |
| 归属于母公司股东的综合收益总额 | 45,416,541.7 | 32,126,202.56 | 24,475,009.16 | 50,411,061.41 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-28 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |